Current Research Studies

Cancer - AHODO831: A Non-Randomized Phase III Study of Response Adapted Therapy for the Treatment of Children with Newly Diagnosed High Risk Hodgkin Lymphoma

Condition or Therapy:

Hodgkin lymphoma

Category:

Cancer and blood disorders
Study Number: AHODO831

What is the goal of this study?

The goals of this study is to understand how well giving combination chemotherapy together with radiation therapy works in treating young patients with newly diagnosed Hodgkin lymphoma.

Who can join the study?

This study may be a good for children and young adults who:

  • Are ages of 0 to 21 years old, and
  • Have been newly diagnosed with classical Hodgkin lymphoma or nodular lymphocyte-predominant Hodgkin lymphoma in all stage III with B symptoms or all stage IV with B symptoms.

What will happen if my child takes part in this study?

You can read about the study protocol on clinicaltrials.gov.

Who can I contact for more information?

For more information, please call 206-987-2106 or send us an email.


Study Location(s):

Seattle Children's Main Hospital Campus

Principal Investigator:

Dr. Douglas Hawkins